[HTML][HTML] Mammographic breast density and the risk of breast cancer: A systematic review and meta-analysis

FTH Bodewes, AA Van Asselt, MD Dorrius… - The Breast, 2022 - Elsevier
Objectives Mammographic density is a well-defined risk factor for breast cancer and having
extremely dense breast tissue is associated with a one-to six-fold increased risk of breast …

A review of nanotechnology-based approaches for breast cancer and triple-negative breast cancer

V Jain, H Kumar, HV Anod, P Chand, NV Gupta… - Journal of Controlled …, 2020 - Elsevier
Breast cancer (BC) is one of the most prevalent cancers in women. Triple-negative breast
cancer (TNBC) in which the three major receptors ie estrogen receptor (ER), progesterone …

[HTML][HTML] Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI)

RM Mann, A Athanasiou, PAT Baltzer… - European …, 2022 - Springer
Breast density is an independent risk factor for the development of breast cancer and also
decreases the sensitivity of mammography for screening. Consequently, women with …

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

F Cardoso, S Kyriakides, S Ohno… - Annals of …, 2019 - annalsofoncology.org
In 2018, the predicted number of new breast cancers in 28 European Union (EU) countries
was 404 920, with estimated age-adjusted annual incidence of breast cancer of 144.9/100 …

Breast cancer early detection: A phased approach to implementation

O Ginsburg, CH Yip, A Brooks, A Cabanes, M Caleffi… - Cancer, 2020 - Wiley Online Library
When breast cancer is detected and treated early, the chances of survival are very high.
However, women in many settings face complex barriers to early detection, including social …

Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors

B Waissengrin, A Agbarya, E Safadi, H Padova… - The Lancet …, 2021 - thelancet.com
Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated
with immune checkpoint inhibitors - The Lancet Oncology Skip to Main Content …

Stand-alone artificial intelligence for breast cancer detection in mammography: comparison with 101 radiologists

A Rodriguez-Ruiz, K Lång… - JNCI: Journal of the …, 2019 - academic.oup.com
Background Artificial intelligence (AI) systems performing at radiologist-like levels in the
evaluation of digital mammography (DM) would improve breast cancer screening accuracy …

National health system characteristics, breast cancer stage at diagnosis, and breast cancer mortality: a population-based analysis

C Duggan, D Trapani, AM Ilbawi, E Fidarova… - The Lancet …, 2021 - thelancet.com
Background In some countries, breast cancer age-standardised mortality rates have
decreased by 2–4% per year since the 1990s, but others have yet to achieve this outcome …

The Global Breast Cancer Initiative: a strategic collaboration to strengthen health care for non-communicable diseases

BO Anderson, AM Ilbawi, E Fidarova… - The Lancet …, 2021 - thelancet.com
The worldwide burden of cancer is substantial and growing. More than one in six deaths
globally are due to cancer, with 19 million new cancer cases and 10 million new cancer …

[HTML][HTML] Global challenges in breast cancer detection and treatment

CH Barrios - The Breast, 2022 - Elsevier
Breast cancer represents an urgent global priority. While this is a universal issue, and as the
burden of the disease is increasing globally, current estimates indicate that in the next …